Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Siriraj Hospital Expands Services to Provide Advanced Medical Care, Highlights State-of-the-Art Technology for Cancer Treatment

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

Cure Brain Cancer Foundation CEO Lance Kawaguchi Completes SouthPoleTrek4Cancer, Raises Over $1 Million for Cancer Research

Read more ››
By: PR Newswire Association LLC. - 25 Feb 2024

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies

Read more ››
By: GlobeNewswire - 25 Feb 2024

Operation Smile and Beast Philanthropy Spotlight Global Need for Access to Surgical Care

Read more ››
By: PR Newswire Association LLC. - 25 Feb 2024

Groundbreaking! Phase II Data of LP-003 Unveiled by Longbio Pharma at AAAAI2024

Read more ››
By: PR Newswire Association LLC. - 25 Feb 2024

Omalizumab Increases the Reaction Threshold for Peanut and Other Common Food Allergies

Read more ››
By: PR Newswire Association LLC. - 25 Feb 2024

New England Journal of Medicine publishes Phase III data showing Xolair® (omalizumab) significantly reduced allergic reactions across multiple foods in people with food allergies

Read more ››
By: PR Newswire Association LLC. - 25 Feb 2024

Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria

Read more ››
By: GlobeNewswire - 24 Feb 2024

Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria

Read more ››
By: GlobeNewswire - 24 Feb 2024

China Medical University Hospital's Breakthrough: Leg Salvage Against Deadly Arterial Disease. Amputation and Death Rates Plunge from 30% to Below 3%

Read more ››
By: PR Newswire Association LLC. - 24 Feb 2024

Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®

Read more ››
By: GlobeNewswire - 24 Feb 2024

Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®

Read more ››
By: GlobeNewswire - 24 Feb 2024

Easterseals South Florida announces the appointment of Matthew Roth as Board Chair

Read more ››
By: PR Newswire Association LLC. - 24 Feb 2024

AMYLYX PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. - AMLX

Read more ››
By: PR Newswire Association LLC. - 24 Feb 2024

APhA Statement on Change Healthcare Cyberattack

Read more ››
By: PR Newswire Association LLC. - 24 Feb 2024

The Howard and Georgeanna Jones Foundation for Reproductive Medicine supports Alabama infertility patients

Read more ››
By: PR Newswire Association LLC. - 24 Feb 2024

Starton Therapeutics to Present at BIO CEO & Investor Conference 2024

Read more ››
By: GlobeNewswire - 23 Feb 2024

IBEX Files Management Proxy Circular for Sale of the Company at $1.45 Per Share

Read more ››
By: GlobeNewswire - 23 Feb 2024

Ibogaine By David Dardashti Unravels the Science of Glial Cells

Read more ››
By: GlobeNewswire - 23 Feb 2024

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 23 Feb 2024
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate